Loss of speech or movement has become listed as serious COVID-19 symptom in the new update of WHO. 

To read full information click this link.

ACS have created a Surgeon Toolkit for discussions with patients in order to facilitate surgeons' activity.

For further information Click this link

ACS has created a Surgeon Toolkit for discussions with patients in order to facilitate surgeons' activity.

For further information Click this link

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread to most countries, with WHO declaring a COVID-19 pandemic on March 11, 2020. The pandemic has tested the resilience of health-care systems, including hospitals, which were largely unprepared for the scale of the pandemic. Patients having surgery are a vulnerable group at risk of SARS-CoV-2 exposure in hospital and might be particularly susceptible to subsequent pulmonary complications, due to the pro-inflammatory ...

As lockdowns ease, thermal imaging cameras are popping up in all sorts of public places to assess the state of people's health. In this report you will find some tips regarding thermal imaging cameras. 


Click here for reference

Governments around the world are responding to the novel coronavirus (COVID-19) pandemic with unprecedented policies designed to slow the growth rate of infections. Many actions, such as closing schools and restricting populations to their homes, impose large and visible costs on society, but their benefits cannot be directly observed and are currently understood only through process-based simulations. Here, we compile new data on 1,717 local, regional, and national non-pharmaceutical int...

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.


Convalescent plasma disappoints in Chinese trial

Hydroxychloroquine fails to protect against infection in key trial


Timing, location of sample may impact coronavirus test results

Click here for reference

A $2bn procurement fund aimed at ensuring that poorer countries can access doses of a potential coronavirus vaccine has been announced at a virtual summit hosted by the UK.



The announcement was made at the third Gavi vaccine alliance replenishment summit, a virtual pledging event that separately raised $8.8bn, above the target of $7.4bn, for the private-public alliance’s general work on immunising millions of people worldwide from longstanding diseases such as measles.
<...

In late 2019, China reported a cluster of atypical pneumonia cases of unknown etiology in Wuhan. The causative agent was identified as a new betacoronavirus, called severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), that causes coronavirus disease 2019 (COVID-19). The virus rapidly spread across the globe and caused a pandemic. Sequencing of the viral genome allowed for the development of nucleic acid–based tests that have since been widely used for the diagnosis of acute (curr...

Fitbit, the company known for its fitness wearables, announced on Wednesday that it has received emergency use authorization (EUA) from the US Food & Drug Administration (FDA) for a new emergency ventilator, which Fitbit designed in response to the COVID-19 global health crisis.An automatic resuscitator, Fitbit Flow was inspired by the MIT E-Vent Design Toolbox, and based on specifications for Rapidly Manufactured Ventilation Systems. Fitbit consulted with clinicians at Oregon Health &...

When COVID-19 hit, SPEE3D founders Byron Kennedy and Steve Camilleri tried to work out how they could prevent the spread of the virus, and decided to investigate if antimicrobial copper could be the key.

According to Kennedy, copper has been known to kill viruses and bacteria for centuries, so they decided to research if it would kill this specific coronavirus.


Click here for reference

The USA's leading infectious disease expert Dr. Anthony Fauci said he’s “cautiously optimistic” a coronavirus vaccine will provide some protection against SARS-CoV-2 and COVID-19, the illness it causes, but is concerned about how long that protection could last.

In an interview with JAMA editor-in-chief Howard Bauchner Tuesday, the director of the National Institute of Allergy and Infectious Diseases questioned the "durability" of candidate vaccines.

Click here for reference...